Recently, the first orally-administered ultra-long acting insulin was shown to have clinical efficacy. Here, the authors report the molecular engineering, as well as the biological and pharmacological properties of these insulin analogues.
- Frantisek Hubálek
- Hanne H. F. Refsgaard
- Thomas Kjeldsen
